Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

CLBS

Caladrius Biosciences (CLBS)

Caladrius Biosciences Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:CLBS
일자시간출처헤드라인심볼기업
2023/05/1005:11Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CLBSCaladrius Biosciences Inc
2023/05/1005:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLBSCaladrius Biosciences Inc
2023/05/0205:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLBSCaladrius Biosciences Inc
2023/03/3105:17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CLBSCaladrius Biosciences Inc
2023/02/0706:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLBSCaladrius Biosciences Inc
2023/01/1807:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLBSCaladrius Biosciences Inc
2023/01/1306:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLBSCaladrius Biosciences Inc
2023/01/1206:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLBSCaladrius Biosciences Inc
2023/01/1206:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLBSCaladrius Biosciences Inc
2023/01/1206:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLBSCaladrius Biosciences Inc
2023/01/1206:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLBSCaladrius Biosciences Inc
2023/01/1206:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLBSCaladrius Biosciences Inc
2023/01/1206:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLBSCaladrius Biosciences Inc
2023/01/1206:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLBSCaladrius Biosciences Inc
2022/11/1106:16Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CLBSCaladrius Biosciences Inc
2022/11/1106:13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLBSCaladrius Biosciences Inc
2022/10/1805:03Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CLBSCaladrius Biosciences Inc
2022/10/1505:02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:CLBSCaladrius Biosciences Inc
2022/09/1705:52Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLBSCaladrius Biosciences Inc
2022/09/1705:51Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLBSCaladrius Biosciences Inc
2022/09/1705:47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLBSCaladrius Biosciences Inc
2022/09/1705:46Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLBSCaladrius Biosciences Inc
2022/09/1522:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLBSCaladrius Biosciences Inc
2022/09/1522:15GlobeNewswire Inc.Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata TherapeuticsNASDAQ:CLBSCaladrius Biosciences Inc
2022/09/1506:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLBSCaladrius Biosciences Inc
2022/09/1421:00GlobeNewswire Inc.Caladrius Biosciences Announces Approval of Merger and Name Change to Lisata TherapeuticsNASDAQ:CLBSCaladrius Biosciences Inc
2022/09/1221:35GlobeNewswire Inc.Life Sciences Virtual Investor Conference Agenda Announced for September 15thNASDAQ:CLBSCaladrius Biosciences Inc
2022/09/0821:00GlobeNewswire Inc.Caladrius Biosciences Announces Participation in Upcoming Investor Conferences in September 2022NASDAQ:CLBSCaladrius Biosciences Inc
2022/09/0305:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLBSCaladrius Biosciences Inc
2022/08/2001:34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLBSCaladrius Biosciences Inc
 검색 관련기사 보기:NASDAQ:CLBS